| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 01/08/2003 | EP1272461A1 Alpha-sulfin- and alpha-sulfonamino acid amide derivatives |
| 01/08/2003 | EP1272460A1 Novel alpha-sulfin- and alpha-sulfonamino acid amide derivatives |
| 01/08/2003 | EP1272456A1 Hydrazide and alkoxyamide angiogenesis inhibitors |
| 01/08/2003 | EP1196500B1 Reactive dye compounds |
| 01/08/2003 | EP0996439B1 Beta-alkoxyacrylates against malaria |
| 01/08/2003 | CN1390204A Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 01/08/2003 | CN1098255C Novel substituted piperazine derivatives having tachyknin receptor antagonists activity |
| 01/07/2003 | US6504031 Enzyme inhibitor such as 6-(2-(1-isopropyl-1,2,3,4-tetrahydro -7-isoquinolinyl)ethenyl)-2-naphthalenecarboximidamide, used as angiogenesis inhibitors; antiarthritic, antiinflammatory and antitumor agents |
| 01/07/2003 | US6503909 Administering as antiepileptic or anticonvulsant agents; treating central nervous system disorders with dihydrofolate reductase inhibitors; side effect reduction |
| 01/03/2003 | WO2003000688A1 Azaindoles |
| 01/03/2003 | WO2003000666A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000663A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000262A1 Vinyl phenyl derivatives as glk activators |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2002088101A3 Inhibitors of bace |
| 01/03/2003 | CA2455292A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | CA2450491A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | CA2450475A1 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/02/2003 | US20030004181 Disubstituted bicyclic heterocycles, the preparation thereof, and their use as pharmaceutical compositions |
| 01/02/2003 | US20030004169 Modulators of dopamine neurotransmission |
| 01/02/2003 | US20030004137 Muscle relaxants, controlling immunology, strokes, antidiabetic agents |
| 01/02/2003 | EP1268455A2 Piperazine derivatives |
| 01/02/2003 | EP1268454A1 Succinoylamino heterocycles as inhibitors of a-beta protein production |
| 01/02/2003 | EP1268443A1 2-hydroxy-mutilin carbamate derivatives for antibacterial use |
| 01/02/2003 | EP1267819A2 Preparation containing quinoxaline derivatives |
| 12/31/2002 | US6500948 Metalloproteinase inhibitors-compositions, uses preparation and intermediates thereof |
| 12/31/2002 | US6500863 Interleukin binding inhibitors such as n-(2-hydroxyl-3-amino sulfonyl-4-chlorophenyl)-n'-(2-bromophenyl)urea, used for prophylaxis of chemokine mediated diseases |
| 12/31/2002 | US6500822 Benzocycloalkylenylamine derivatives as muscarinic receptor antagonists |
| 12/27/2002 | WO2002102983A2 Oligomers and polymers of di-substituted cyclic imino carboxylic acids |
| 12/27/2002 | WO2002102787A2 Novel sulfonic acid derivatives |
| 12/27/2002 | WO2002102380A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 12/27/2002 | WO2002102372A1 Gem-disubstituted cyclohexane derivatives and their use as therapeutic agents |
| 12/27/2002 | CA2429113A1 Monocyclic or bicyclic carbocycles and heterocycles as factor xa inhibitors |
| 12/26/2002 | US20020198210 Alpha-2-adrenergic agonist/fatty acid compositions |
| 12/26/2002 | US20020198207 Novel Hexanoic acid derivatives |
| 12/26/2002 | US20020198195 New oxybenzamide derivatives useful for inhibiting factor Xa or VIIa |
| 12/26/2002 | US20020198184 Matrix metalloproteinase inhibitor is useful as an anticancer agent, angiogenesis inhibitor, a tumor cell infiltration inhibitor or a tumor metastasis inhibitor; inflammatory diseases, osteoarthritis, rheumatoid arthritis |
| 12/25/2002 | CN1097052C Process for production of amidinoindole derivs, and salts thereof |
| 12/24/2002 | US6498275 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 12/24/2002 | US6498252 Pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 12/24/2002 | US6498172 Prostaglandin agonists and their use to treat bone disorders |
| 12/24/2002 | US6498162 Treating inflammatory and allergic diseases of respiratory tract and diseases of central nervous system |
| 12/24/2002 | CA2150812C Catechol diethers as selective pde iv inhibitors |
| 12/19/2002 | WO2002101003A2 Stereoselective preparation of cyclic l-amino acids |
| 12/19/2002 | WO2002100838A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators |
| 12/19/2002 | WO2002100822A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/19/2002 | WO2002070541A3 Peptide deformylase inhibitors |
| 12/19/2002 | US20020193596 Inhibitors of protein isoprenyl transferases |
| 12/19/2002 | US20020193383 1-(N-phenylalkylaminoalkyl)piperazine derivatives substituted at position 2 of the phenyl ring |
| 12/19/2002 | US20020193382 Sulfonamide derivatives, their production and use |
| 12/19/2002 | CA2450262A1 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines as crf1 receptor modulators |
| 12/19/2002 | CA2445653A1 Substituted sulfonamide compounds, process for their use as medicament for the treatment of cns disorders, obesity and type ii diabetes |
| 12/18/2002 | EP1267495A1 RF receiver having cascaded filters and an intermediate amplifier stage |
| 12/18/2002 | EP1267170A1 Method for characterising polypeptides |
| 12/18/2002 | EP1265866A2 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof |
| 12/18/2002 | EP0843658B1 Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 12/18/2002 | CN1096450C Process for producing phenoxy propionic acid derivatives |
| 12/18/2002 | CN1096446C N-(ortho-substd-benzyloxy)imine derivs, and their use as fungicides, acaricides or insecticides |
| 12/17/2002 | US6495716 For use as a biodegradative chelating agent for a detergents, photographic bleaching agent, an electroless plating assistant and a peroxide stabilizer |
| 12/17/2002 | US6495686 Therapy for psychological disorders |
| 12/17/2002 | US6495681 Local anesthetic compounds and uses |
| 12/17/2002 | US6495576 N-(1-((3,4-dioxo-2-(3-pyridinylamino)-1-cyclobuten-1-yl)amino) -2,2-dimethylpropyl)-4-methylbenzamide for example; treating bladder overactivity, benign prostatic hyperplasia, premature labor, and sexual disorders |
| 12/13/2002 | WO2001096332A1 Process for the preparation of a piperazine derivative |
| 12/13/2002 | CA2412873A1 Process for the preparation of a piperazine derivative |
| 12/12/2002 | WO2002099124A2 Characterising polypeptides |
| 12/12/2002 | WO2002098864A1 Pyrimidine, triazine and pyrazine derivatives as glutamate receptors |
| 12/12/2002 | WO2002098849A2 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases |
| 12/12/2002 | US20020188119 Method of preparing enantiomerically-enriched tetrahydrobenzothiepine oxides |
| 12/12/2002 | CA2449942A1 Characterising polypeptides |
| 12/12/2002 | CA2448834A1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
| 12/11/2002 | EP1263711A1 Novel use of phenylheteroalkylamine derivatives |
| 12/11/2002 | EP0837854B1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists |
| 12/10/2002 | US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds. |
| 12/10/2002 | US6492517 The present invention relates to a method for preparing 5- and 6-halomethyl quinoxalines in presence of a radical initiator in a solvent selected from the group consisting of fluorobenzene, difluorobenzenes, trifluorobenzenes, |
| 12/10/2002 | US6492412 Prevention of loss and restoration of bone mass by certain prostaglandin agonists |
| 12/10/2002 | US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 12/10/2002 | US6492362 Compounds and compositions as cathepsin S inhibitors |
| 12/10/2002 | US6492351 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 12/09/2002 | WO2002004403A1 Biphenylcarboxylic acid amides, production thereof and use thereof as medicaments |
| 12/09/2002 | CA2412116A1 Biphenylcarboxylic acid amides, the preparation thereof and the use thereof as medicaments |
| 12/05/2002 | WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 12/05/2002 | WO2002096858A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 12/05/2002 | US20020183342 For use as insecticides against a variety of insects, including larvae, such as tobacco budworm |
| 12/05/2002 | US20020183324 Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors |
| 12/05/2002 | US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy |
| 12/05/2002 | CA2448894A1 Cinnamide derivatives as kcnq potassium channel modulators |
| 12/05/2002 | CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production |
| 12/04/2002 | EP1261590A1 Piperidine- and piperazine substituted n-hydroxyformamides as inhibitors of metalloproteinases |
| 12/04/2002 | CN1383424A Aryl and heteroacrylcyclopropyl oxime ethers and their use as fungicides |
| 12/03/2002 | US6489483 Reacting acetyl-substituted pyridine derivative with 3-aminoacrolein, reacting reaction product with ammonia or ammonium salt |
| 12/03/2002 | US6489327 Tryptase inhibitors |
| 12/03/2002 | US6489324 Piperazine compounds as inhibitors of MMP or TNF |
| 12/03/2002 | CA2266107C Aralkyl and aralkylidene heterocyclic lactams and imides |
| 11/28/2002 | WO2002094796A2 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases |
| 11/28/2002 | WO2002094766A1 Phthalamide derivative, agricultural or horticultural insecticide, and use thereof |
| 11/28/2002 | WO2002048106A3 Isoindolin-1-one glucokinase activators |
| 11/28/2002 | US20020177598 Inhibit activity of chemokines, macrophage inflammatory protein-1 (MIP-1 alpha) and RANTES; 1-((4-chlorophenoxy)methyl)-carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine for example |
| 11/28/2002 | US20020177596 2,3,4,4a,5,6-hexahydro-1H-pyrazino(1,2-a)quinoxaline derivatives; treating depression, schizophrenia; (5-hydroxytryptamine=5HT) 5HT2a antagonist or a 5HT2c agonist |
| 11/28/2002 | US20020177578 3-hydroxy-4-methoxypyridine-2-carboxyamides N-substituted with a benzyl 9-member dilactone ring |
| 11/27/2002 | EP1259551A1 Polymerization compositions and methods |